Wells Fargo’s Adial Pharmaceuticals Warrant ADILW Stock Holding History

Wells Fargo’s Portfolio ADILW Stock Details ADILW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,000	Closed	-$86	–	7781
2023 Q2	$86	Buy	+15,000	New	+$341	﹤0.01%	6905

Wells Fargo's ADILW Position: Q3 2023 in Review

Wells Fargo sold out of Adial Pharmaceuticals Warrant (ADILW) in Q3 2023, closing a stake of 15,000 shares — an estimated $86 sold.

Wells Fargo first reported a position in ADILW in Q2 2023 and held it in 1 quarter. The position peaked at $86 in Q2 2023. 0 funds tracked by Wall St. Rank hold ADILW as of Q3 2023.

Wells Fargo reported no remaining Adial Pharmaceuticals Warrant position as of Q3 2023 after selling out during the quarter.
Wells Fargo sold 15,000 Adial Pharmaceuticals Warrant shares in Q3 2023, an estimated $86.
Wells Fargo first reported a position in Adial Pharmaceuticals Warrant in Q2 2023 and held it in 1 quarter.
Wells Fargo's Adial Pharmaceuticals Warrant position peaked at $86 in Q2 2023.
0 funds tracked by Wall St. Rank held Adial Pharmaceuticals Warrant as of Q3 2023.

Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.